For research use only. Not for therapeutic Use.
Efbemalenograstim alfa（Cat No.:I042078）is an investigational biosimilar to the recombinant human granulocyte colony-stimulating factor (G-CSF), used to stimulate the production of white blood cells, particularly neutrophils. It is being developed to treat conditions that cause neutropenia, such as chemotherapy-induced neutropenia and certain bone marrow disorders. By promoting the growth of neutrophils, a key component of the immune system, efbemalenograstim alfa helps reduce the risk of infections in patients with low white blood cell counts. Clinical trials are underway to evaluate its safety, efficacy, and potential as an alternative treatment for these conditions.
| Catalog Number | I042078 |
| CAS Number | 2200269-79-8 |
| Purity | ≥95% |
